These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37676374)

  • 1. Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder.
    Yan H; Wang Y; Li Y; Shen X; Ma L; Wang M; Du J; Chen W; Xi X; Li B
    Neurol Sci; 2024 Feb; 45(2):709-718. PubMed ID: 37676374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis.
    Liang S; Qin Q; Tang Y; Liao W; Yang Y; He J; Li L
    Ann Palliat Med; 2020 Mar; 9(2):324-330. PubMed ID: 32268769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders.
    Shi L; Li D; Zhang Y; Wang J; Fu J; Liu X; Wang P
    Eur J Med Res; 2023 Oct; 28(1):426. PubMed ID: 37821922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neutrophil-to-Lymphocyte Ratio and the Monocyte-to-Lymphocyte Ratio Predict Expanded Disability Status Scale Score at One Year in Pediatric Neuromyelitis Optica Spectrum Disorder but not in Multiple Sclerosis.
    Devlin L; Gombolay G
    Pediatr Neurol; 2023 Jun; 143():84-88. PubMed ID: 37044044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Lazaro L; Alonso R; Fernández Liguori N; Tkachuk V; Caride A; Rojas JI
    Mult Scler Relat Disord; 2022 Feb; 58():103507. PubMed ID: 35030372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
    Kim SM; Waters P; Vincent A; Go MJ; Park KS; Sung JJ; Lee KW
    J Neurol; 2011 Dec; 258(12):2176-80. PubMed ID: 21594697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study.
    Xie H; Zhao Y; Pan C; Zhang J; Zhou Y; Li Y; Duan R; Yao Y; Gong Z; Teng J; Jia Y
    BMC Neurol; 2021 Oct; 21(1):389. PubMed ID: 34625035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders.
    Fang X; Sun S; Yang T; Liu X
    Front Neurosci; 2023; 17():1097490. PubMed ID: 37090792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients.
    You X; Yan L; Li X; Pang Y; Guo X; Ye J; Hu H
    Mult Scler Relat Disord; 2019 Jan; 27():254-259. PubMed ID: 30419511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.
    Lin L; Wu Y; Hang H; Lu J; Ding Y
    Front Immunol; 2022; 13():853891. PubMed ID: 35898513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enlarged perivascular spaces, neuroinflammation and neurological dysfunction in NMOSD patients.
    Yao XY; Gao MC; Bai SW; Xie L; Song YY; Ding J; Wu YF; Xue CR; Hao Y; Zhang Y; Guan YT
    Front Immunol; 2022; 13():966781. PubMed ID: 36248814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Yuan C; Liu X; Cai S; Zhang L; Guo R; Jia Z; Sun Y; Li B
    Mult Scler Relat Disord; 2023 Feb; 70():104504. PubMed ID: 36623394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33 as a Biomarker Affecting Intrathecal Synthesis of Immunoglobulin in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
    Wang M; Xia D; Sun L; Bi J; Xie K; Wang P
    Eur Neurol; 2023; 86(4):256-262. PubMed ID: 37100033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD.
    Wang L; Xia R; Li X; Shan J; Wang S
    Front Immunol; 2023; 14():1293100. PubMed ID: 38259484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
    Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
    J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders.
    Li J; He Y; Wang H; Chen J
    Brain Behav; 2022 Dec; 12(12):e2798. PubMed ID: 36306394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.
    Carnero Contentti E; Delgado-García G; Criniti J; López PA; Pettinicchi JP; Cristiano E; Miguez J; Correa-Díaz EP; Álvarez Pucha MO; Miño Zambrano JE; Gómez-Figueroa E; Rivas-Alonso V; Flores-Rivera J; Tkachuk V; Caride A; Rojas JI
    Front Immunol; 2021; 12():628024. PubMed ID: 33717149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
    Liang J; Liu J; Fan R; Chen Z; Chen X; Tong J; Chen Y; Peng F; Jiang Y
    Neuroimmunomodulation; 2019; 26(5):258-264. PubMed ID: 31655825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imagenologic significance of the neutrophil-to-lymphocyte ratio in neuromyelitis optica spectrum disorder: A systematic review with meta-analysis.
    Cabanillas-Lazo M; Cruzalegui-Bazán C; Pascual-Guevara M; Quispe-Vicuña C; Terry-Escalante FA; Mori N; Alva-Díaz C
    PLoS One; 2023; 18(2):e0281064. PubMed ID: 36758016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.